🔎 Trials Near Me

Home › Autism Spectrum Disorder › NCT04322734

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

RecruitingObservational studyHealthy volunteers welcome

Who can join

Up to age 18 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria (ASD):

1. ASD, as defined by either a gold standard measure for ASD diagnosis, the Autism Diagnostic Observation Schedule (ADOS); the Autism Diagnostic Interview-Revised (ADI-R); and/or a comprehensive assessment that is consistent with ASD, in the opinion of the principal investigator. For those the PI believes a prospective diagnosis of ASD is warranted, a formal diagnostic assessment will be scheduled at screening.
2. 0 years through 17 years 11 months of age

Inclusion Criteria (TD, MD, Epilepsy, Brain Tumor, Psychiatric)

1\. 0 years to 17 years 11 months of age

Exclusion Criteria (All):

1. History of a significant adverse reaction to a prior blood draw
2. In females of reproductive age, pregnancy or plans to become pregnant
3. Any other historical event/information that may, in the opinion of the PI, be a reason to exclude the child from participation.

About the study

The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate.

This study is currently recruiting.

There is no cost for visits or study-related exams.

Sponsor: Southwest Autism Research & Resource Center · Participants: 500 · Started: Dec 13, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT04322734

Locations in the U.S.

ArizonaSouthwestern Research and Resource Center, Phoenix
New YorkState University of New York, Downstate, Brooklyn

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.